 Enveric Biosciences NASDAQ:ENVB said it is working with the University of Calgarys Hotchkiss Brain Institute HBI, a leading neurosciences center of excellence at the Cumming School of Medicine in Calgary, to establish a groundbreaking clinical trial of EVM-101 for the treatment of cancer-related distress CRD. A clinical trial of EVM-101, a first-generation psychedelic treatment, expected to launch later this year, will be led by HBI researcher, Dr. 